Hi Owl Just finished watching the whole video. Indeed worth watching. Our families have a long history of DKD and CKD. A couple kidney transplants at 40s and dialysis due to genetic, dietary and general lifestyle reasons, or simply lack of health knowledge in those early years. I’m kind of an “expert” in diabetics so to speak. Sadly.
I’m very emotional in finding a cure or solution for DKD, or early prevention etc. 100% agree that cross promotion is not right but I truly like PIQ to be more exposed one way or the other for the sake of the their well-being. I respect your integrity.
Towards the end of the AGM @42minute, Dr Lipscombe said, “The FDA has put out strong guideline on any drugs coming thru clinical trial should have a biomarker that identifies how that drug behaves when that drug goes thru the clinical trial, ie, early identification of the outcome of the drug. This part is very exciting ! Big revenue opportunity for PIQ and huge potential cost savings for companies doing any new drug trials.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)